Inscripta – The Digital Genome Engineering Company
Inscripta is developing the world’s first scalable platform for benchtop digital genome engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, reagents, and software, offers a fully automated workflow that enables multiplexed, trackable editing of cells at an unprecedented scale. Inscripta’s goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations. By providing this unique platform and engaging in collaborative business practices, such as making its MAD7 CRISPR nuclease free for research purposes, the company enables scientists to realize a new era of biological discovery.
If you would like to learn more about Inscripta you can visit their website at Inscripta.com or view the videos and applications below:
- Get an overview of the Onxy Platform (0:39)
- See how the Onyx Platform works (5:24)
- Hear about Sestina Bio’s use of the Onyx Platform (5:22)
See examples of applications using the Onyx technology:
- Learn how Inscripta increased the production of lysine in E.coli 14,000 times
- Download the application note: Rapid target discovery in microbes using massively parallel genome engineering
- Download the application note: Onyx Digital Genome Engineering Platform to ease and enhance Adaptive Laboratory Evolution experiments
This content was supplied by Inscripta.
